Pharmalicensing.com: PR Newswire http://pharmalicensing.com/rss/ Latest market and business intelligence from the leading publishers worldwide. en-us Pharmalicensing.com: PR Newswire http://pharmalicensing.com/rss/ http://pharmalicensing.com/images/pharmalicensing_logo.gif 144 Tramacet(R) Builds Gr LONDON, February 16 /PRNewswire/ -- From 1st January Gr http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2556 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2556 Mon, 16 Feb 2009 12:02:00 +0000 Simbionix and Johnson & Johnson LLC Announce Distribution Agreement at Russia and the CIS Countries CLEVELAND, Ohio, April 16 /PRNewswire/ -- Simbionix, the world's leading developer of medical simulation systems, today announced an agreement with Johnson & Johnson LLC for distribution of... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2889 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2889 Thu, 16 Apr 2009 08:10:00 +0000 Kingfisher Healthcare (KFH) Receives FDA Clearance to Market KFH Energy in the USA And Raises EUR1 Million to Accelerate Market Penetration LEUVEN, Belgium, March 31 /PRNewswire/ -- Kingfisher Healthcare, a young healthcare company focused on improving patient quality of life, announced today that the U.S. Food and Drug Administration... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/636 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/636 Mon, 31 Mar 2008 07:00:00 +0000 Successful Inspection of Helsinn Birex Pharmaceuticals Dublin, Ireland by the US Food and Drug Administration DUBLIN, Ireland, July 22 /PRNewswire/ -- Helsinn is pleased to announce that Helsinn Birex Pharmaceuticals, its drug facility in Dublin, Ireland, has undergone a successful inspection by the US Food... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1431 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1431 Tue, 22 Jul 2008 11:56:00 +0000 Cambridge Laboratories Announces FDA Approval of XENAZINE(R) (tetrabenazine) in the US LONDON, August 18 /PRNewswire/ -- Cambridge Laboratories Group Limited ("Cambridge"), the privately owned specialty pharmaceutical company, announces today that XENAZINE(R) (tetrabenazine), the first... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1538 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1538 Mon, 18 Aug 2008 07:00:00 +0000